1. Home
  2. AXSM vs CGNX Comparison

AXSM vs CGNX Comparison

Compare AXSM & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • CGNX
  • Stock Information
  • Founded
  • AXSM 2012
  • CGNX 1981
  • Country
  • AXSM United States
  • CGNX United States
  • Employees
  • AXSM N/A
  • CGNX N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • CGNX Industrial Machinery/Components
  • Sector
  • AXSM Health Care
  • CGNX Industrials
  • Exchange
  • AXSM Nasdaq
  • CGNX Nasdaq
  • Market Cap
  • AXSM 6.3B
  • CGNX 5.3B
  • IPO Year
  • AXSM 2015
  • CGNX 1989
  • Fundamental
  • Price
  • AXSM $111.67
  • CGNX $30.01
  • Analyst Decision
  • AXSM Strong Buy
  • CGNX Buy
  • Analyst Count
  • AXSM 14
  • CGNX 12
  • Target Price
  • AXSM $168.93
  • CGNX $46.42
  • AVG Volume (30 Days)
  • AXSM 593.1K
  • CGNX 2.2M
  • Earning Date
  • AXSM 05-05-2025
  • CGNX 05-01-2025
  • Dividend Yield
  • AXSM N/A
  • CGNX 1.06%
  • EPS Growth
  • AXSM N/A
  • CGNX N/A
  • EPS
  • AXSM N/A
  • CGNX 0.62
  • Revenue
  • AXSM $385,693,000.00
  • CGNX $914,515,000.00
  • Revenue This Year
  • AXSM $64.53
  • CGNX $8.70
  • Revenue Next Year
  • AXSM $63.26
  • CGNX $10.96
  • P/E Ratio
  • AXSM N/A
  • CGNX $48.17
  • Revenue Growth
  • AXSM 42.53
  • CGNX 9.19
  • 52 Week Low
  • AXSM $64.11
  • CGNX $29.29
  • 52 Week High
  • AXSM $139.13
  • CGNX $53.13
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 36.05
  • CGNX 35.46
  • Support Level
  • AXSM $117.60
  • CGNX $30.36
  • Resistance Level
  • AXSM $122.97
  • CGNX $31.80
  • Average True Range (ATR)
  • AXSM 4.47
  • CGNX 0.90
  • MACD
  • AXSM -1.66
  • CGNX 0.01
  • Stochastic Oscillator
  • AXSM 20.13
  • CGNX 22.36

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: